Leadership Team

The Leadership Team at Facile Therapeutics is responsible for strategizing and guiding the company's clinical development efforts for Ebselen, ensuring its efficacy in preventing the recurrence of CDI. This team collaborates closely on scientific direction, regulatory compliance, and strategic partnerships, leveraging their extensive expertise to drive the Proof-of-Concept clinical trial toward successful outcomes.